UnitedHealth Group stock at EUR 305.50, up 1.77% premarket
Published on 11/20/2026 at 08:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- UnitedHealth Group's investor materials identify medical-cost management and Medicare and CMS changes among key business risks.
- The company lists third-quarter 2026 results among its latest investor reports.
UnitedHealth Group stock traded at EUR 305.50 on Lang & Schwarz at 08:35 CET on Friday, November 20, 2026, 1.77 percent above the Xetra close of Thursday, November 19, 2026, at EUR 300.20.
The insurer's investor materials highlight medical-cost management, Medicare and CMS rules, government-program funding and legal actions as factors that can affect operations and financial performance. These issues remain important for investors assessing the group's earnings recovery and execution.
UnitedHealth Group lists its third-quarter 2026 results among its latest investor reports. The company's investor-relations materials also identify changes in healthcare laws, Medicare and the CMS star ratings program as risks to revenue and costs. Further company updates will be assessed against those operating priorities.
The broader S&P 500 provides the relevant US market backdrop for UnitedHealth Group.
